Neuromuscular Fellowship Funding Competition Recipients
The Neuromuscular Disease Network for Canada (NMD4C) together with Muscular Dystrophy Canada (MDC) are excited to announce the recipients of a funding competition, which awarded national post-doctoral fellowships in neuromuscular research and clinical fellowships in neuromuscular medicine and electromyography.
This competition saw many incredible applicants and involved a thorough and extensive review by leading Canadian neuromuscular researchers and clinicians to ensure the most promising and top-ranked researchers, and leaders in neuromuscular care, received funding.
Post-doctoral fellowship recipients:
Dr. Yuguo Liu
Université de Sherbrooke
Post-doctoral Supervisor: Dr. Florian Bentzinger
Title of Research: Targeting the Perivascular MuSC Niche for the Treatment of Muscular Dystrophy
Sean Ng, Ph.C.
McMaster University
Post-doctoral Supervisors: Dr. Mark Tarnopolsky and Dr. Joshua Nederveen
Title of Research: Determining the Therapeutic Potential of AMP-activated Protein Kinase in Myotonic Dystrophy Type 2
Dr. Matthew Triolo
University of Ottawa
Post-doctoral Supervisor: Dr. Mireille Khacho
Title of Research: Targeting mitochondrial dynamics and metabolites to restore muscle stem cell function in Duchenne Muscular Dystrophy
Clinical fellowship recipients:
Dr. Gloria Mak
Training institution: University of Alberta
Dr. Béatrice Soucy
Training institution: University of Calgary
Dr. Neha Patel
Training institution: Sunnybrook Health Sciences Centre, University of Toronto
NMD4C and MDC extend special thanks to the Canadian Society of Clinical Neurophysiologists (CSCN) for jointly funding a clinical fellow this year.
Read next...
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.
MICYRN Secures $20 Million Grant from CIHR for a Pediatric Rare Disease Clinical Trials and Treatment Network
The NMD4C are excited to share that MICYRN’s success in securing a $20 million grant from CIHR Institute of Genetics to support the development and execution of RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network.